ISTA PHARMACEUTICALS INC·4

Feb 6, 9:04 PM ET

Davis Glenn Eugene 4

4 · ISTA PHARMACEUTICALS INC · Filed Feb 6, 2012

Insider Transaction Report

Form 4
Period: 2012-02-02
Davis Glenn Eugene
VP Legal & Chief Comp. Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2012-02-02$8.18/sh314$2,56929,205 total
Footnotes (1)
  • [F1]1-25% of the original award vested. A portion of the vested shares were traded to cover income taxes.

Documents

1 file
  • 4
    rrd332917.xmlPrimary

    DAVIS GLENN E--FORM 4